In the following Clinical Researcher article, Worldwide Clinical Trials’ Global Head of Regulatory Strategy, Aman Khera, discusses how global regulatory agencies are acting as a supportive resource for sponsors through accommodations for industry advancements such as new technologies and expanding expedited pathways for drug development.
Authors:
Aman Khera, MBA, FTOPRA, FRAPS
VP, Regulatory Science, Strategy and Innovation
